Advertisement

14.6% Sodium Chloride Concentrated Solution for Injection

[27 June 2016]

Products Affected - Description

14.6% Sodium Chloride solution for injection, Hospira
40 mL vial, 25 count (NDC 00409-6660-75)

Reason for the Shortage

Hospira has 14.6% sodium chloride solutions for injection on shortage due to manufacturing delays.

Available Products

14.6% Sodium Chloride solution for injection, Fresenius Kabi
40 mL vial, 25 count (NDC 63323-0139-40)
 
14.6% Sodium Chloride solution for injection, Hospira
20 mL vial, 25 count (NDC 00409-6657-73)

Estimated Resupply Dates

Hospira has 14.6% sodium chloride concentrated solution in 40 mL vials on back order and the company estimates a release date of 3rd quarter 2016.

Related Shortages

Updated

June 27, 13 and 9, May 24, April 11, March 1, February 22, 10 and 4, 2016; December 8, September 28, 15 and 3, July 14 and 2, June 1, March 25, January 23, 2015; November 14, October 7, September 8, August 6, July 11, May 9, April 14, March 26, January 17, 2014; December 10, November 13, October 15, September 25, August 30 and 27, July 11 and 3, June 27 and 11, May 30 and 10, March 29, February 22, January 8, 2013; December 10, November 15, October 24, September 27, August 8, June 28, May 15, April 4, March 20, February 23, January 18, 2012; December 14, November 9, September 20, August 24, July 28, June 16, May 23, April 28, March 22, February 17, January 26, 2011; December 14 , November 19, October 29, September 23, August 13, July 12, May 18, April 23, March 31, 17 and 3, February 17, 2010, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing